Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Aneurysm Treatment Devices Market $4.5 Billion by 2027

The global market for aneurysm treatment devices expected to cross $4.5 billion by 2027, growing at a CAGR of 5.2% over the forecast period, driven by increasing incidence of hypertension (high blood pressure), smoking and genetic predisposition, higher preference for minimally invasive procedures, ageing population and rapid progress of product development for embolization devices in the recent years.

Global Aneurysm Treatment Devices Market

An aneurysm is the enlargement of an artery caused by weakness in the arterial wall. Aneurysms often occur in the aorta, brain, back of the knee, intestine or spleen. The causes of aneurysms are sometimes unknown. A family history of aneurysm may increase the risk for developing an aneurysm. Other risk factors include high blood pressure, high cholesterol and smoking.

  • The aneurysm devices for treating cerebral and peripheral include a wide range of coils, particles, glues, stents, embolic protection devices and microcatheters, among others.
    • Factors contributing to the formation of cerebral aneurysms include hypertension (high blood pressure), cigarette smoking, congenital (genetic) predisposition, injury or trauma to blood vessels, and complication from some types of blood infections.
  • Peripheral aneurysms affect arteries other than the aorta or the brain. It mostly affects the arteries in legs or neck. The risk factors include smoking, high blood pressure, high cholesterol, obesity, family history of heart or vascular disease, and aging population.

In the recent past, various endovascular methods have been developed to treat large numbers of aneurysms. The main strategic and technical modifications introduced to date include balloon-assisted coil embolization, stent-assisted coil embolization, flow diverters, and flow disrupters.

  • For example, for the treatment of brain aneurysms, endovascular options continue to evolve. Recently, the U.S. FDA approved a device known as the Woven EndoBridge (WEB), which can offer a new minimally invasive option that can deliver a curative treatment for some of the most challenging aneurysm cases.

The global market for aneurysm treatment devices report provides market size ($million 2017 to 2027), market share analysis, growth trends and forecast (CAGR%, 2021 to 2027).


The global market for devices for treating cerebral and peripheral aneurysms segmented by product [therapeutic embolization devices (embolization coils, embolization beads/particles, others), surgical procedure devices (vascular access site closure devices), circulatory disorder management devices (bare metal stents), and geography.

  • Based on products, the therapeutic embolization devices segment accounted for the largest share of the total market, owing to increasing product development activity in embolization devices, including coils, glues and particles.
    • The embolization coils sub-segment dominated the global market and is anticipated to grow at the fastest rate during the forecast period.
      • The growth of embolization coils market attributed to large number of approved products and rapid uptake in the market.
      • The Major companies such as Johnson & Johnson, Terumo Corporation and Keneka Medix Corporation have the most approved devices in the market, globally.

Endovascular coiling, surgical clipping, and flow diverters are some of the prominent treatment modalities used for treating an intracranial aneurysm.

  • Coil embolization technique used to treat brain aneurysms by placing detachable coils within the aneurysm. Endovascular coiling is a minimally invasive procedure performed to block blood flow into an aneurysm.
    • The coils used in this procedure are made of soft platinum metal, and are shaped like a spring. The coiling procedure may be performed to treat an unruptured brain aneurysm and a ruptured brain aneurysm in some cases, as well as for older patients or for those that cannot undergo surgery.
      • Endovascular coiling is an attractive option for treating aneurysms because it does not require opening of the skull, and is generally accomplished in a shorter time frame, which lessens the anesthesia given.

The flow disruption is a technique used to treat wide-neck brain aneurysms by placing a single, intrasaccular device within the aneurysm, altering the intra-aneurysmal flow.

  • The WEB Embolization System is first-in-class intrasaccular technology offering a single-device treatment alternative to endovascular coils and complex stenting procedures.
    • The intrasaccular embolization system minimizes the need for a dual antiplatelet regimen required for intraluminal therapies.

The flow diversion (FD) technique uses a low porosity stent across a wide-necked brain aneurysm. The device is placed across the aneurysm neck opening, and extends into the parent artery on both sides.

  • This alters intra-aneurysmal blood flow patterns and redirects flow away from the aneurysm. Flow diverter stents were introduced about 7 years ago into the clinical armamentarium of the neuro-interventionists as an additional tool for aneurysm treatment.
    • They have higher metal surface area coverage (~30-35%) as compared to the previous generation stents which have ~8-10% metal surface-area coverage.

The global market for aneurysm treatment devices research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the North America region held the largest revenue share of the global market, followed by the Europe region.
    • Factors such as increasing prevalence of hypertension (high blood pressure), smoking habits and family history of heart or vascular disease, preference for minimally invasive procedures, rapidly growing elderly population and technological developments.
  • However, the Asia Pacific region is expected to expand at the fastest CAGR in the coming years.
    • The development and introduction of aneurysm treatment devices have been so persistent and rapid that new devices are being approved worldwide even before the earlier ones become available in some countries.

In addition, the global market for aneurysm treatment devices report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major competitors operating in the global market for aneurysm treatment devices and profiled in this report include BALT Extrusion SAS, Johnson & Johnson, Keneka Medix Corporation, Medtronic plc, Penumbra, Inc., Phenox GmbH, Stryker Corporation, and Terumo Corporation.

  • Product
    • Therapeutic Embolization Devices
      • Embolization Coils
      • Embolization Beads/Particles
      • Others
    • Surgical Procedure Devices
      • Vascular Access Site Closure Devices
    • Circulatory Disorder Management Devices
      • Bare Metal Stents
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • BALT Extrusion SAS
    • Johnson & Johnson
    • Keneka Medix Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Phenox GmbH
    • Stryker Corporation
    • Terumo Corporation

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/aneurysms-treatment-devices-market/

Related publications:



    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]